Darvon, a controversial prescription painkiller, was pulled off the market shelves on Friday at the request of federal regulators because apparently there are concerns that the drug can cause fatal heart problems. The company that makes Darvon, called Xanodyne Pharmaceuticals Inc., located in Newport, Kentucky, agreed to withdraw the medication at the request of the FDA. Also, companies making generic versions of the drug, known as propoxyphene, will also be removing their products from the market. This removal is being put into action because the FDA recently received new data that shows that the drug puts patients at risk for potentially fatal heart rhythm abnormalities. This is an example of how government is stepping in and socially regulating this product to make sure it does not threaten the public health, safety, welfare, or well-being of citizens.
http://www.washingtonpost.com/wp-dyn/content/article/2010/11/19/AR2010111905867.html
Kilee Imlay
Subscribe to:
Post Comments (Atom)
The conclusion reached about this drug is a comforting one due to the fact that researchers and scientists are gaining some sort of an insight on prescription drugs. With the amount of prescription drugs out there, all patients cannot possibly know exactly what the drug is or what the side effects might be. It has been said that doctors have recently been prescribing a more frequent amount of drugs to patients. It is crucial that the FDA stay on top of their research with certain drugs due to all the unknown effects that have yet to be discovered.
ReplyDelete- Matthew DiPietrantonio